[go: up one dir, main page]

FI904756A0 - STABILIZER LEUKOCYT-INTERFERONER. - Google Patents

STABILIZER LEUKOCYT-INTERFERONER.

Info

Publication number
FI904756A0
FI904756A0 FI904756A FI904756A FI904756A0 FI 904756 A0 FI904756 A0 FI 904756A0 FI 904756 A FI904756 A FI 904756A FI 904756 A FI904756 A FI 904756A FI 904756 A0 FI904756 A0 FI 904756A0
Authority
FI
Finland
Prior art keywords
interferoner
leukocyt
stabilizer
stabilizer leukocyt
Prior art date
Application number
FI904756A
Other languages
Finnish (fi)
Other versions
FI904756A7 (en
Inventor
Alberto Ferro
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI904756A0 publication Critical patent/FI904756A0/en
Publication of FI904756A7 publication Critical patent/FI904756A7/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI904756A 1989-09-28 1990-09-27 Stabilized leukocyte interferons FI904756A7 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH351489 1989-09-28

Publications (2)

Publication Number Publication Date
FI904756A0 true FI904756A0 (en) 1990-09-27
FI904756A7 FI904756A7 (en) 1991-03-29

Family

ID=4257630

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904756A FI904756A7 (en) 1989-09-28 1990-09-27 Stabilized leukocyte interferons

Country Status (26)

Country Link
EP (1) EP0420049B1 (en)
JP (1) JPH03130232A (en)
KR (1) KR910005886A (en)
CN (1) CN1050503A (en)
AR (1) AR244551A1 (en)
AT (1) ATE92334T1 (en)
AU (1) AU636653B2 (en)
CA (1) CA2024046A1 (en)
CZ (1) CZ277712B6 (en)
DD (1) DD298054A5 (en)
DE (1) DE59002183D1 (en)
FI (1) FI904756A7 (en)
HU (1) HU205555B (en)
IE (1) IE903479A1 (en)
IL (1) IL95769A0 (en)
IS (1) IS3631A7 (en)
MC (1) MC2149A1 (en)
MX (1) MX22522A (en)
MY (1) MY106615A (en)
NO (1) NO904218L (en)
NZ (1) NZ235153A (en)
PH (1) PH27531A (en)
PT (1) PT95454A (en)
RU (1) RU2008017C1 (en)
YU (1) YU184090A (en)
ZA (1) ZA907579B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028020A1 (en) * 1993-05-18 1994-12-08 Bukh Meditec A/S A method for the preparation of interferons
AU2401197A (en) * 1996-05-09 1997-11-26 Feronpatent Limited Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets
EP1007083A1 (en) * 1997-05-09 2000-06-14 Feronpatent Limited Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
US6180096B1 (en) 1998-03-26 2001-01-30 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
TWI243057B (en) * 1998-03-26 2005-11-11 Schering Corp Formulations for protection of peg-interferon alpha conjugates
CN1175901C (en) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 Stable water solution of interferon
US7632491B2 (en) 2004-08-12 2009-12-15 Schering Corporation Stable pegylated interferon formulation
DE102004048379A1 (en) 2004-10-01 2006-04-13 "Stiftung Caesar" (Center Of Advanced European Studies And Research) Spring element made of sputtered shape memory alloy
CU23432B6 (en) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech STABILIZED FORMULATIONS CONTAINING GAMMA AND ALFA INTERFERONS IN POTENTIAL PROPORTIONS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (en) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd Purifying method of interferon
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
ATE31023T1 (en) * 1983-04-28 1987-12-15 Armour Pharma PHARMACEUTICAL PREPARATION CONTAINING PURIFIED FIBRINONECTIN.
EP0133767B1 (en) * 1983-08-04 1991-04-03 The Green Cross Corporation Gamma interferon composition
GR860758B (en) * 1985-03-25 1986-07-21 Schering Corp Stable gamma - interferon formulation
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones

Also Published As

Publication number Publication date
YU184090A (en) 1992-09-07
IE903479A1 (en) 1991-04-10
PT95454A (en) 1991-05-22
NO904218L (en) 1991-04-02
CA2024046A1 (en) 1991-03-29
ATE92334T1 (en) 1993-08-15
CZ277712B6 (en) 1993-03-17
RU2008017C1 (en) 1994-02-28
PH27531A (en) 1993-08-18
AU6309890A (en) 1991-04-11
ZA907579B (en) 1991-06-26
NO904218D0 (en) 1990-09-27
EP0420049A1 (en) 1991-04-03
HUT56284A (en) 1991-08-28
AU636653B2 (en) 1993-05-06
EP0420049B1 (en) 1993-08-04
IS3631A7 (en) 1991-03-29
NZ235153A (en) 1993-03-26
JPH03130232A (en) 1991-06-04
MY106615A (en) 1995-06-30
FI904756A7 (en) 1991-03-29
DE59002183D1 (en) 1993-09-09
HU205555B (en) 1992-05-28
DD298054A5 (en) 1992-02-06
KR910005886A (en) 1991-04-27
MC2149A1 (en) 1992-03-10
AR244551A1 (en) 1993-11-30
CS432890A3 (en) 1992-12-16
IL95769A0 (en) 1991-06-30
HU906021D0 (en) 1991-03-28
CN1050503A (en) 1991-04-10
MX22522A (en) 1993-10-01

Similar Documents

Publication Publication Date Title
FI914133A0 (en) SVAENGBAR KOPPLINGSANORDNING.
FI891717A0 (en) KVADRATURMODULATOR.
DE69002184D1 (en) STABILIZER.
DE69017059D1 (en) Multi-turntable.
FI891341L (en) ROERFOERBINDNING FOER VENTILATIONSANORDNINGAR.
DE59003341D1 (en) Suspension.
DE69012802D1 (en) STABILIZER ROD.
FI910566A0 (en) STABILIZER POLYMERLATEXKOMPOSITION.
NO900159D0 (en) SUSPENSION.
DE69011984D1 (en) Suspension element.
FI891499A0 (en) FICKVENTILATIONSFOERFARANDE OCH -ANORDNING.
FI904756A0 (en) STABILIZER LEUKOCYT-INTERFERONER.
DE69010340D1 (en) SUSPENSION ARRANGEMENT.
DE69004689D1 (en) N-FLUOROPYRIDINIUM-PYRIDINE-HEPTAFLUORODIBORATE.
FI904567A0 (en) STABILIZER FORMING.
DE69001981D1 (en) KAEFIGMUTTER.
FI895850A0 (en) VAONINGSSAENG.
FI871027A0 (en) STABILIZER SLIRSKYDD FOER FORDONSDAECK.
FI890408A0 (en) CYLINDERTORK.
DE59001865D1 (en) TURN CROSS.
FI892404L (en) LEDAR CLAIM.
DE59004250D1 (en) DIGITALIZER.
ES1011220Y (en) BAG-BRIEFCASE.
ES1011331Y (en) CHAIR-HAMMOCK.
ATE101099T1 (en) MICRODOSER.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: F. HOFFMANN - LA ROCHE AG